Financhill
Back

Cognition Therapeutics Stock Predictions

Cognition Therapeutics Stock Forecast

  • Is Cognition Therapeutics Stock Undervalued?
    The current Cognition Therapeutics [CGTX] share price is $0.44. The Score for CGTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • CGTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Cognition Therapeutics Stock Go Up Next Year?

Data Unavailable

Cognition Therapeutics Stock Rating

Data Unavailable

Cognition Therapeutics Stock Price History

Is CGTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cogrx.com

52-Week Data

52-Week High:
2.95
52-Week Low:
0.34

Prediction Charts

Market Cap:
18.27M
Price in USD:
0.44
Volume:
503.16K
Beta:
1.33

Technical Analysis

SMA50:
0.49
SMA100:
0.82
SMA200:
1.40
52-Wk Change:
-56.02%

Stock Predictions

  • Is Cognition Therapeutics stock public?
    Yes, Cognition Therapeutics is a publicly traded company.
  • What is the Cognition Therapeutics stock quote today?
    The Cognition Therapeutics stock price is 0.44 USD today.
  • How to buy Cognition Therapeutics stock online?
    You can buy Cognition Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 0.47 0.47 0.49 0.44
Nov-5 0.47 0.49 0.51 0.47
Nov-6 0.52 0.50 0.52 0.49
Nov-7 0.52 0.52 0.53 0.51
Nov-8 0.50 0.51 0.52 0.50
Nov-11 0.51 0.51 0.52 0.48
Nov-12 0.51 0.60 0.62 0.50
Nov-13 0.60 0.54 0.60 0.53
Nov-14 0.53 0.51 0.54 0.50
Nov-15 0.50 0.46 0.51 0.46
Nov-18 0.48 0.46 0.49 0.46
Nov-19 0.45 0.44 0.46 0.43
Nov-20 0.44 0.44 0.47 0.43
Nov-21 0.44 0.44 0.45 0.43

Cognition Therapeutics Earnings

Data Unavailable

Cognition Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.16 per share.

* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.